We decided to point our attention to BAF modulation of CCL2, as this chemokine has been already linked to BBB damage in several inflammatory and infectious disorders, such as atherosclerosis and MS (Gschwandtner et al. 2019), and also to S1P signaling (Li et al. 2014). The gene discussed is CCL2; the disease is myeloid sarcoma.